Fairmount Funds Management’s Soleno Therapeutics SLNO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,142,473	Closed	-$33.7M	–	19
2023 Q3	$33.7M	Buy	+1,142,473	New	+$33.7M	4.06%	9